U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07390747) titled 'A Trial of SHR-2173 in Healthy Volunteers' on Jan. 29.
Brief Summary: The purpose of this study is to assess safety, PK, Pharmacodynamic and immunogenicity profile of a single dose of SHR-2173 in healthy participants
Study Start Date: March 15
Study Type: INTERVENTIONAL
Condition:
Immunology
Intervention:
DRUG: SHR-2173 Injection/SHR-2173 placebo
Single dose SHR-2173 injection or matching placebo given subcutaneously
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Atridia Pty Ltd.
Disclaimer: Curated by HT Syndication....